GPhA Rebrands Itself and Changes its Name to the Association for Accessible Medicines February 17, 2017 By NIcholas Hamm GPhA, the generic drug industry’s leading trade organization, adopted a new name: the Association for Accessible Medicines (AAM). The new name reflects the organization's mission “to make more medicines more accessible to more people who need them.” Considering Specialty Pharmacy? Make Your Move February 16, 2017 By Jill Sederstrom There is a lot for growth in specialty pharmacy but chains and independent pharmacies should make their move soon if they want to enter this market. The window of opportunity is closing. How to Deal with an Angry Customer February 16, 2017 Retail pharmacists get tips on how to deal with angry customers. Beyond Beta-Blockers: Ivabradine for CHF February 16, 2017 Review of new drug Ivabradine (Corlanor) approved by the FDA for the management of heart failure. $96.5 Million Generic Payout Latest Trouble for Mylan February 15, 2017 By Christine Blank A $96.5 million settlement is the latest in a series of pricing and competition issues Mylan has faced in the past year. How New Biosimilars Will Impact the Market February 15, 2017 By Christine Blank More biosimilars are coming onto the market , including competitors for Remicade and Neulasta. Safety Concerns Over Some Hepatitis C Drugs February 13, 2017 By Anthony Vecchione The ISMP has issued a report that links several direct-acting antiviral agents for hepatitis C to serious adverse side effects. But drug makers take issue. Getting Reimbursed for Services Rendered: It’s no Magic Trick February 10, 2017 By Peter A. Kreckel RPh Pharmacists use their expertise to help patients -- as well as insurance companies. But we do it for free!